Member Info for achilles

02-Sep-21 16:28:33 2.791582 2,500,000 Buy* 2.75 2.80 69.79k O

where is the RNS??

Phase III result is the biggie, the link below is the interview with Dr Nadya Lisovoder on the phase II clinical study of 50 patients with moderate COVID-19 symptoms, definitely worth a read.

https://www.yumpu.com/en/document/view/65797234/artemic-interview

plenty more of news to come this month, AMC to get regulatory approval, phase 3 interim results, just be patient cause Mgc is definitely heading in the right direction

The upside here is huge, take GW Pharma as a good example.

GW Pharma is the first company to receive FDA approval for medicine derived from the cannabis plant.

GW Pharmaceuticals stock soared 46% on Wednesday after Jazz Pharma said it would buy the company for $7.2 billion.

The proposed deal will include $200 in cash and $20 in shares of Jazz Pharma, and is expected to close in the second quarter of 2021.

· MGC Pharma has been granted government approval to import its phytomedicine CimetrA™ into India as a final step towards obtaining Emergency Use Authorisation for the treatment of patients with COVID-19.

· Emergency Use Authorisation is the registration process for medicines approved for the treatment of COVID-19 around the world.

· Emergency Use Authorisation would enable MGC Pharma to market and sell CimetrA™ as an approved medicine for the treatment of COVID-19 in India, and potentially in other territories under international Mutual Recognition protocols for medicines.

· Medopharm Private Ltd (Medopharm), one of the leading manufacturers and exporters of pharmaceutical products in India, is managing the Emergency Use Authorisation process for CimetrA™ in India on MGC Pharma's behalf.

· Medopharm has been appointed importer for CimetrA™ in India once the Emergency Use Authorisation has been granted

· CimetrA™ is currently undergoing Phase III trial for the treatment of COVID-19 l in Israel

Fantastic news!

MGC Pharma has been granted government approval to import its phytomedicine CimetrA™ into India as a final step towards obtaining Emergency Use Authorisation for the treatment of patients with COVID-19.

lets get the interim results out ASAP, sitting at 2.6p is a joke

Aren't covid results due in August? Hopefully it will be released next week

lack of patience

3.7 will seem very cheap in the coming months, yesterday's RNS was an absolute game changer

topped up, what a gift under 3p! MXC is way ahead of its competitions

a lot people will be dumping when the Q2 results are out, any rise will be short lived, the sentiment has been very poor since the relisting

someone is accumulating in the background, cant see any large buys but the SP is going up, thats fine by me!

ABDX went crazy on Monday afternoon, we should see the same here, strong bounce off 3.2p

ABDX

double dip reversal, should bounce from here

christ, why sell at the open when its 70% down, it was obviously gonna bounce

https://stocktwits.com/symbol/MGCLF

The yanks are going nuts on Stocktwits, cant wait for this afternoon! I suspect 3.6 will look very cheap by then :)